サマリー

豚用ワクチンの世界市場 2022-2026 年
Technavioは豚のワクチン市場を監視しており、2022年から2026年の間に794.67百万ドル、予測期間中に7.01％のCAGRで進行し成長することが予測されています。当レポートでは、豚用ワクチン市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向と推進要因、市場全体の環境に関する最新分析を提供しています。市場は、豚の疾病の有病率の増加、豚用ワクチン開発のためのR&D支出の増加、動物医療支出の増加によって牽引されています。
ブタ用ワクチン市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのブタ用ワクチン市場は、以下のように区分されています。
製品別
- 静脈内投与
- 筋肉内投与
- その他
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の豚ワクチン市場の成長を促進する主要な理由の1つとして、市場ベンダーによる戦略的イニシアチブを挙げています。また、豚肉とゼラチンの需要の増加と、畜産部門に資金を提供するための政府のイニシアチブの増加が、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。ブタ用ワクチン市場に関する当レポートは、以下の分野をカバーしています。
- 豚用ワクチン市場のサイジング
- 豚用ワクチン市場の予測
- 豚用ワクチン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Bimeda Inc.、Bioveta AS、Boehringer Ingelheim International GmbH、Ceva Sante Animale、Elanco Animal Health Inc、FATRO SpA、Formosa Biomedical Inc.、LABORATORIOS HIPRA SA、Merck and Co.Inc.、Phibro Animal Health Corp.、Veterinary Provisions Inc.、Vetoquinol SA、Virbac Group、およびZoetis Inc.が含まれます。また、ブタワクチン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/porcine-vaccine-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Intravenous - Market size and forecast 2021-2026
o Exhibit 28: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
o 5.4 Intramuscular - Market size and forecast 2021-2026
o Exhibit 32: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bioveta AS
o Exhibit 89: Bioveta AS - Overview
o Exhibit 90: Bioveta AS - Product / Service
o Exhibit 91: Bioveta AS - Key offerings
o 10.4 Boehringer Ingelheim International GmbH
o Exhibit 92: Boehringer Ingelheim International GmbH - Overview
o Exhibit 93: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 94: Boehringer Ingelheim International GmbH - Key news
o Exhibit 95: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 96: Boehringer Ingelheim International GmbH - Segment focus
o 10.5 Ceva Sante Animale
o Exhibit 97: Ceva Sante Animale - Overview
o Exhibit 98: Ceva Sante Animale - Product / Service
o Exhibit 99: Ceva Sante Animale - Key offerings
o 10.6 FATRO SpA
o Exhibit 100: FATRO SpA - Overview
o Exhibit 101: FATRO SpA - Product / Service
o Exhibit 102: FATRO SpA - Key offerings
o 10.7 Formosa Biomedical Inc.
o Exhibit 103: Formosa Biomedical Inc. - Overview
o Exhibit 104: Formosa Biomedical Inc. - Product / Service
o Exhibit 105: Formosa Biomedical Inc. - Key offerings
o 10.8 LABORATORIOS HIPRA SA
o Exhibit 106: LABORATORIOS HIPRA SA - Overview
o Exhibit 107: LABORATORIOS HIPRA SA - Product / Service
o Exhibit 108: LABORATORIOS HIPRA SA - Key offerings
o 10.9 Merck and Co. Inc.
o Exhibit 109: Merck and Co. Inc. - Overview
o Exhibit 110: Merck and Co. Inc. - Business segments
o Exhibit 111: Merck and Co. Inc. - Key news
o Exhibit 112: Merck and Co. Inc. - Key offerings
o Exhibit 113: Merck and Co. Inc. - Segment focus
o 10.10 Phibro Animal Health Corp.
o Exhibit 114: Phibro Animal Health Corp. - Overview
o Exhibit 115: Phibro Animal Health Corp. - Business segments
o Exhibit 116: Phibro Animal Health Corp. - Key offerings
o Exhibit 117: Phibro Animal Health Corp. - Segment focus
o 10.11 Virbac Group
o Exhibit 118: Virbac Group - Overview
o Exhibit 119: Virbac Group - Business segments
o Exhibit 120: Virbac Group - Key news
o Exhibit 121: Virbac Group - Key offerings
o Exhibit 122: Virbac Group - Segment focus
o 10.12 Zoetis Inc.
o Exhibit 123: Zoetis Inc. - Overview
o Exhibit 124: Zoetis Inc. - Business segments
o Exhibit 125: Zoetis Inc. - Key news
o Exhibit 126: Zoetis Inc. - Key offerings
o Exhibit 127: Zoetis Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 11.5 List of abbreviations
o Exhibit 134: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bioveta AS - Overview
Exhibits90: Bioveta AS - Product / Service
Exhibits91: Bioveta AS - Key offerings
Exhibits92: Boehringer Ingelheim International GmbH - Overview
Exhibits93: Boehringer Ingelheim International GmbH - Business segments
Exhibits94: Boehringer Ingelheim International GmbH - Key news
Exhibits95: Boehringer Ingelheim International GmbH - Key offerings
Exhibits96: Boehringer Ingelheim International GmbH - Segment focus
Exhibits97: Ceva Sante Animale - Overview
Exhibits98: Ceva Sante Animale - Product / Service
Exhibits99: Ceva Sante Animale - Key offerings
Exhibits100: FATRO SpA - Overview
Exhibits101: FATRO SpA - Product / Service
Exhibits102: FATRO SpA - Key offerings
Exhibits103: Formosa Biomedical Inc. - Overview
Exhibits104: Formosa Biomedical Inc. - Product / Service
Exhibits105: Formosa Biomedical Inc. - Key offerings
Exhibits106: LABORATORIOS HIPRA SA - Overview
Exhibits107: LABORATORIOS HIPRA SA - Product / Service
Exhibits108: LABORATORIOS HIPRA SA - Key offerings
Exhibits109: Merck and Co. Inc. - Overview
Exhibits110: Merck and Co. Inc. - Business segments
Exhibits111: Merck and Co. Inc. - Key news
Exhibits112: Merck and Co. Inc. - Key offerings
Exhibits113: Merck and Co. Inc. - Segment focus
Exhibits114: Phibro Animal Health Corp. - Overview
Exhibits115: Phibro Animal Health Corp. - Business segments
Exhibits116: Phibro Animal Health Corp. - Key offerings
Exhibits117: Phibro Animal Health Corp. - Segment focus
Exhibits118: Virbac Group - Overview
Exhibits119: Virbac Group - Business segments
Exhibits120: Virbac Group - Key news
Exhibits121: Virbac Group - Key offerings
Exhibits122: Virbac Group - Segment focus
Exhibits123: Zoetis Inc. - Overview
Exhibits124: Zoetis Inc. - Business segments
Exhibits125: Zoetis Inc. - Key news
Exhibits126: Zoetis Inc. - Key offerings
Exhibits127: Zoetis Inc. - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations